Cost-effective analysis of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s10067-017-3725-3
Published Online: 2017-06-21
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Syngle, Ashit
Kaur, Sudeep
Verma, Inderjeet
Syngle, Tanya
Syngle, Vijaita
License valid from 2017-06-21